Bioceres Crop Solutions (BIOX) Current Deferred Revenue (2017 - 2026)

Bioceres Crop Solutions has disclosed Current Deferred Revenue across 10 years of filings, most recently posting $2.8 million for Q1 2026.

• In Q1 2026, Current Deferred Revenue fell 27.5% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (down 27.5% YoY), while the FY2025 annual figure was $4.3 million, up 9.61% from the prior year.
• Current Deferred Revenue came in at $2.8 million for Q1 2026 at Bioceres Crop Solutions, up from $2.5 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $44.1 million in Q4 2022 to a low of $2.3 million in Q3 2025.
• Average Current Deferred Revenue over 5 years is $12.0 million, with a median of $5.5 million recorded in 2024.
• Year-over-year, Current Deferred Revenue soared 12160.2% in 2022 and sank 86.74% in 2024.
• Over 5 years, Current Deferred Revenue stood at $44.1 million in 2022, then plunged by 49.93% to $22.1 million in 2023, then slumped by 86.74% to $2.9 million in 2024, then fell by 14.73% to $2.5 million in 2025, then rose by 12.09% to $2.8 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $2.8 million in Q1 2026, $2.5 million in Q4 2025, and $2.3 million in Q3 2025.